Logo

pneumonia

Pattern Bio's Single-Cell Clinical Microbiology Platform Wins ADLM Disruptive Tech Competition
Premium

The company uses microfluidics and machine learning to identify pathogens and conduct phenotypical antibiotic susceptibility testing without culturing.

OpGen, Fisher Healthcare Ink Distribution Deal for Unyvero MDx System

The nonexclusive distribution partnership is expected to increase US commercial adoption of the highly multiplexed PCR system.

Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium

Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.

Curetis to Assist BioVersys' Antibacterial Drug Trial With Unyvero Platform

BioVersys will use the Unyvero HPN in its drug trial to test hospitalized trial candidates for antibiotic-resistant Acinetobacter infections.

OpGen Unyvero Pneumonia Panel Helps Curb Inappropriate Antibiotic Use in Prospective Trial
Premium

The company expects the trial results to bolster sales by increasing physician confidence in the panel.

Mar 1, 2021

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

May 19, 2020

BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases

Apr 21, 2020

Curetis, Karolinska Institute Collaborate to Identify Bacterial Co-Infections in COVID-19 Patients

Mar 9, 2020

Ortho Clinical Diagnostics Procalcitonin Assay Receives FDA Clearance

Dec 20, 2019

FDA Clears Curetis Lower Respiratory Tract Infections Panel

Nov 1, 2019

Swiss Study Underscores Concerns About Procalcitonin Testing for Pneumonia
Premium

Jul 11, 2019

Cancer, Vascular Events, Infections Account for Vast Majority of Misdiagnosis-Related Harm, Study Says

Apr 11, 2019

Curetis 2018 Revenues Grow 17 Percent

Feb 6, 2019

AstraZeneca Spinoff Entasis Inks Deal to Use BioFire Tests

Feb 4, 2019

Curetis Partner Submits MDx System, Pneumonia Test for Chinese Regulatory Approval

Jan 30, 2019

Curetis Receives Malaysia, Thailand Regulatory Approvals

Dec 13, 2018

Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring

Nov 30, 2018

Accelerate Diagnostics Seeks to Improve on 'Gold Standard' Culture Test for Clinical Trials
Premium

Nov 13, 2018

BioMérieux Pneumonia Panels Get FDA 510(k) Clearance, CE Mark

Nov 7, 2018

Avisa Pharma Developing Breath Testing for Pneumonia, C. Diff
Premium

Oct 11, 2018

Curetis Extends Distribution Agreement With Beijing Clear Biotech in China

May 17, 2018

Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test

Apr 19, 2018

BioMérieux Q1 Revenues Up 3 Percent

Apr 4, 2018

Curetis Unyvero System, Lower Respiratory Tract Infection Cartridge Get FDA Clearance

Feb 15, 2018

Accelerate Diagnostics Posts Sharp Q4 Revenue Increase